Drug Shortage Report for TERAZOSIN
Report ID | 23666 |
Drug Identification Number | 02350505 |
Brand name | TERAZOSIN |
Common or Proper name | TERAZOSIN TAB |
Company Name | SANIS HEALTH INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | TERAZOSIN |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | G04CA |
ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2017-10-02 |
Actual start date | |
Estimated end date | 2017-10-31 |
Actual end date | 2017-10-06 |
Shortage status | Resolved |
Updated date | 2017-10-07 |
Company comments | Delay in release of replenishment batch |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2017-10-07 | French | Compare |
v8 | 2017-10-06 | French | Compare |
v7 | 2017-10-06 | English | Compare |
v6 | 2017-10-03 | English | Compare |
v5 | 2017-09-27 | French | Compare |
v4 | 2017-09-27 | English | Compare |
v3 | 2017-09-27 | French | Compare |
v2 | 2017-09-27 | English | Compare |
v1 | 2017-09-27 | English | Compare |
Showing 1 to 9 of 9